BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loktionov A. Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins? World J Gastrointest Oncol 2020; 12(2): 124-148 [PMID: 32104546 DOI: 10.4251/wjgo.v12.i2.124] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Gallardo-Gómez M, De Chiara L, Álvarez-Chaver P, Cubiella J. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Rev Anticancer Ther 2021;21:723-38. [PMID: 33507120 DOI: 10.1080/14737140.2021.1882858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Baszuk P, Marciniak W, Derkacz R, Jakubowska A, Cybulski C, Gronwald J, Dębniak T, Huzarski T, Białkowska K, Pietrzak S, Muszyńska M, Kładny J, Narod SA, Lubiński J, Lener MR. Blood Copper Levels and the Occurrence of Colorectal Cancer in Poland. Biomedicines 2021;9:1628. [PMID: 34829856 DOI: 10.3390/biomedicines9111628] [Reference Citation Analysis]
3 Smith RA, Fedewa S, Siegel R. Early colorectal cancer detection-Current and evolving challenges in evidence, guidelines, policy, and practices. Adv Cancer Res 2021;151:69-107. [PMID: 34148621 DOI: 10.1016/bs.acr.2021.03.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tieng FYF, Abu N, Nasir SN, Lee LH, Ab Mutalib NS. Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells. Diagnostics (Basel) 2021;11:2136. [PMID: 34829483 DOI: 10.3390/diagnostics11112136] [Reference Citation Analysis]
5 Kaufmann Y, Byrum SD, Acott AA, Siegel ER, Washam CL, Mancino AT. Proteomic profiling of tear fluid as a promising non-invasive screening test for colon cancer. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.03.029] [Reference Citation Analysis]
6 He S, Zhou C, Peng H, Lin M. Recent advances in fecal gene detection for colorectal cancer diagnosis. Biomark Med 2021;15:1299-308. [PMID: 34544268 DOI: 10.2217/bmm-2021-0269] [Reference Citation Analysis]
7 Ferrari A, Neefs I, Hoeck S, Peeters M, Van Hal G. Towards Novel Non-Invasive Colorectal Cancer Screening Methods: A Comprehensive Review. Cancers (Basel) 2021;13:1820. [PMID: 33920293 DOI: 10.3390/cancers13081820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kozlowski HN, Sindhwani S, Chan WCW. The Impact of Patient Characteristics on Diagnostic Test Performance. Small Methods 2022;:e2101233. [PMID: 34994108 DOI: 10.1002/smtd.202101233] [Reference Citation Analysis]
9 Pin-Vieito N, Puga M, Fernández-de-Castro D, Cubiella J. Faecal immunochemical test outside colorectal cancer screening? World J Gastroenterol 2021; 27(38): 6415-6429 [PMID: 34720531 DOI: 10.3748/wjg.v27.i38.6415] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mazouji O, Ouhajjou A, Incitti R, Mansour H. Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance. Front Cell Dev Biol 2021;9:660924. [PMID: 34150757 DOI: 10.3389/fcell.2021.660924] [Reference Citation Analysis]
11 Durán-Vinet B, Araya-Castro K, Calderón J, Vergara L, Weber H, Retamales J, Araya-Castro P, Leal-Rojas P. CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review. Cancers (Basel) 2021;13:4640. [PMID: 34572866 DOI: 10.3390/cancers13184640] [Reference Citation Analysis]
12 Vestergaard LK, Oliveira DNP, Høgdall CK, Høgdall EV. Next Generation Sequencing Technology in the Clinic and Its Challenges. Cancers (Basel) 2021;13:1751. [PMID: 33916923 DOI: 10.3390/cancers13081751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 van Liere ELSA, de Boer NKH, Dekker E, van Leerdam ME, de Meij TGJ, Ramsoekh D. Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome. Aliment Pharmacol Ther 2022. [PMID: 35181895 DOI: 10.1111/apt.16824] [Reference Citation Analysis]
14 Pratt M, Forbes JD, Knox NC, van Domselaar G, Bernstein CN. Colorectal Cancer Screening in Inflammatory Bowel Diseases-Can Characterization of GI Microbiome Signatures Enhance Neoplasia Detection? Gastroenterology 2022:S0016-5085(22)00007-5. [PMID: 34998802 DOI: 10.1053/j.gastro.2021.12.287] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pahlavan Y, Mohammadi Nasr M, Dalir Abdolahinia E, Pirdel Z, Razi Soofiyani S, Siahpoush S, Nejati K. Prominent roles of microRNA-142 in cancer. Pathol Res Pract 2020;216:153220. [PMID: 33007646 DOI: 10.1016/j.prp.2020.153220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Pidíková P, Herichová I. miRNA Clusters with Up-Regulated Expression in Colorectal Cancer. Cancers (Basel) 2021;13:2979. [PMID: 34198662 DOI: 10.3390/cancers13122979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Cruz A, Carvalho CM, Cunha A, Crespo A, Iglesias Á, García-Nimo L, Freitas PP, Cubiella J. Faecal Diagnostic Biomarkers for Colorectal Cancer. Cancers (Basel) 2021;13:5568. [PMID: 34771730 DOI: 10.3390/cancers13215568] [Reference Citation Analysis]
18 Arumugaperumal A, Velayudhan Krishna D, Alaguponniah S, Nallaperumal K, Sivasubramaniam S. PeptCreatR: A Web App for Unique Peptides in Human. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10375-4] [Reference Citation Analysis]
19 Bardhi E, Mcdaniels J, Rousselle T, Maluf DG, Mas VR. Nucleic acid biomarkers to assess graft injury after liver transplantation. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100439] [Reference Citation Analysis]
20 Jiang K, Ye T, Du J, Tang L, Chen X, Sun F, Sun X. Elevated P-Element-Induced Wimpy-Testis-Like Protein 1 Expression Predicts Unfavorable Prognosis for Patients with Various Cancers. J Oncol 2021;2021:9982192. [PMID: 35003260 DOI: 10.1155/2021/9982192] [Reference Citation Analysis]
21 Bhardwaj M, Terzer T, Schrotz-King P, Brenner H. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer. Int J Mol Sci 2021;22:1189. [PMID: 33530402 DOI: 10.3390/ijms22031189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Xu F, Yu S, Han J, Zong M, Tan Q, Zeng X, Fan L. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer. Clin Transl Gastroenterol 2021;12:e00386. [PMID: 34382948 DOI: 10.14309/ctg.0000000000000386] [Reference Citation Analysis]
23 Tieng FYF, Abu N, Lee LH, Ab Mutalib NS. Microsatellite Instability in Colorectal Cancer Liquid Biopsy-Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker. Diagnostics (Basel) 2021;11:544. [PMID: 33803882 DOI: 10.3390/diagnostics11030544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Cheng J, Guo Y, Guan G, Huang H, Jiang F, He J, Wu J, Guo Z, Liu X, Ao L. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA. J Cell Mol Med 2021;25:3622-33. [PMID: 33719152 DOI: 10.1111/jcmm.16467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Keenan JI, Frizelle FA. Biomarkers to Detect Early-Stage Colorectal Cancer. Biomedicines 2022;10:255. [PMID: 35203465 DOI: 10.3390/biomedicines10020255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Loktionov A, Soubieres A, Bandaletova T, Francis N, Allison J, Sturt J, Mathur J, Poullis A. Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications. Br J Cancer 2020;123:252-60. [PMID: 32398859 DOI: 10.1038/s41416-020-0893-8] [Reference Citation Analysis]
27 Lou S, Shaukat A. Noninvasive strategies for colorectal cancer screening: opportunities and limitations. Curr Opin Gastroenterol 2021;37:44-51. [PMID: 33074994 DOI: 10.1097/MOG.0000000000000688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Li J, Zhang AH, Wu FF, Wang XJ. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Front Oncol 2022;12:841552. [PMID: 35223525 DOI: 10.3389/fonc.2022.841552] [Reference Citation Analysis]
29 Dong Z, Xue X, Liang H, Guan J, Chang L. DNA Nanomachines for Identifying Cancer Biomarkers in Body Fluids and Cells. Anal Chem 2021;93:1855-65. [PMID: 33325676 DOI: 10.1021/acs.analchem.0c03518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zou J, Xiao Z, Wu Y, Yang J, Cui N. Noninvasive fecal testing for colorectal cancer. Clin Chim Acta 2021:S0009-8981(21)00374-0. [PMID: 34756863 DOI: 10.1016/j.cca.2021.10.030] [Reference Citation Analysis]
31 Lah NAC, Gray R, Trigueros S. Synthesis, characterisation and cytotoxicity of gold microwires for ultra-sensitive biosensor development. Microb Cell Fact 2021;20:46. [PMID: 33596912 DOI: 10.1186/s12934-020-01478-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Zheng L, Zhan Y, Lu J, Hu J, Kong D. A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer. Ann Transl Med 2021;9:680. [PMID: 33987378 DOI: 10.21037/atm-21-1010] [Reference Citation Analysis]